Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
March 10, 2022

Consider migraine screening for all women aged 20 to 50 years, suggests Ailani; you'll likely find a majority of them have migraine. More pearls follow.

Migraine-specific Preventive Therapies Can Be a Primary Care Tool, Leading Investigator Says
March 09, 2022

Migraine-specific preventive therapies should be in the primary care toolbox, according to headache specialist Jessica Ailani, MD.

Migraine Perspectives with Jessica Ailani, MD: Start Migraine Care in Primary Care
March 09, 2022

Migraine headache specialist and researcher Jessica Ailani, MD, fully supports primary care as the setting for the majority of the treatment for the disease.

10 Questions on Migraine Impact, Diagnosis, & Treatment Based on the OVERCOME Study
March 08, 2022

Lifetime use of opioids for migraine was found to be higher than for triptan medications. Try these 10 questions on other OVERCOME findings.

Using Naloxone Against Opioid Use
March 08, 2022

Our panel of doctors and pharmacists introduce naloxone, an opioid antagonist, as an option when treating opioid abuse or overdose.

Challenges With Opioid Use
March 08, 2022

The panel explains the common challenges they find when trying to treat a patient with opioids.

Unmet Needs in US Migraine Headache Management: OVERCOME Study First Data
March 03, 2022

Findings on use of acute and preventive migraine therapy continue to reveal gaps with far more patients eligible than the proportions using either type.

The Opioid Epidemic and Fentanyl
March 01, 2022

A panel of experts discuss the parameters of the opioid epidemic and the role fentanyl plays within it.

Acute Migraine Treatment: A Guide to Medication Options
March 01, 2022

When choosing a migraine treatment for acute attack relief, the American Headache Society suggests following these steps.

2022 Opioid Prescribing Guideline Update Open for Public Comment, says CDC
February 15, 2022

The CDC is inviting public feedback on updated recommendations for opioid prescribing for the first time since the controversial 2016 iteration.